Literature DB >> 8478102

Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A.

J E Domer1, L G Human, G B Andersen, J A Rudbach, G L Asherson.   

Abstract

Monophosphoryl lipid A (MLA), derived either from Salmonella minnesota or Salmonella typhimurium, was tested for its ability to alter Candida albicans mannan (MAN)-specific suppression. Since we showed previously that naive mice injected intravenously (i.v.) with MAN developed suppressor T cells capable of down-regulating delayed-type hypersensitivity when transferred to immunized recipients, MLA was tested for its ability to influence suppressor activity in the donors of suppressor cells. T-lymphocyte-enriched suspensions from donor mice treated with MLA, especially that derived from S. typhimurium, 2 or 3 days after the injection of MAN lost the ability to suppress delayed-type hypersensitivity when transferred to immunized mice. Transferable suppressor activity was reduced but not always completely abrogated when donor animals were treated with MLA 1 day following the administration of MAN. In several experiments, S. minnesota MLA also abrogated activity, but it was not effective in other transfer experiments. In a different type of experiment, MLA was given to immunized mice which had been suppressed directly with MAN. Mice were immunized, either by the introduction of C. albicans intragastrically followed by inoculation intradermally (i.d.) or by two i.d. inoculations, and MAN-specific suppressor cells were induced in such animals by the i.v. injection of MAN 1 day before the first or second i.d. inoculation in animals given intragastric plus i.d. inoculations and those given two i.d. inoculations, respectively. MLA was administered to such mice prior to the i.v. injection of MAN, on the same day, or 1 to 4 days thereafter. S. typhimurium MLA, especially when given to mice 2 days following the administration of MAN, caused a partial abrogation of suppressor activity. Overall, however, MLA, at 5 to 100 micrograms, had variable and minimal effects on suppressor activity in immunized mice suppressed by the i.v. administration of MAN. In summary, MLA is clearly capable of abrogating MAN-induced suppression when given to nonimmunized animals in which MAN-specific suppressor cells had been induced, but its efficacy in immunized animals suppressed by the i.v. administration of MAN was marginal.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8478102      PMCID: PMC280812          DOI: 10.1128/iai.61.5.2122-2130.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

Review 1.  Bacterial cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that enhance protective immunity.

Authors:  G L Gustafson; M J Rhodes
Journal:  Res Immunol       Date:  1992-06

2.  Differential sensitivity of CD8+ suppressor and cytotoxic T lymphocyte activity to bacterial monophosphoryl lipid A.

Authors:  F Esquivel; C E Taylor; P J Baker
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

3.  Stimulation of B-lymphocytes by endotoxin. Reactions of thymus-deprived mice and karyotypic analysis of dividing cells in mice bearing T 6 T 6 thymus grafts.

Authors:  I Gery; J Krüger; S Z Spiesel
Journal:  J Immunol       Date:  1972-04       Impact factor: 5.422

Review 4.  Characterization of the IgG response induced by polyclonal B cell activators.

Authors:  E Severinson; S Bergstedt-Lindqvist; W van der Loo; C Fernandez
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

5.  Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.

Authors:  M S Mitchell; J Kan-Mitchell; R A Kempf; W Harel; H Y Shau; S Lind
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

6.  Splenic T-lymphocyte functions during early syphilitic infection are complex.

Authors:  T J Fitzgerald; M A Tomai
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

Review 7.  Liposomes containing lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine.

Authors:  C R Alving; R L Richards
Journal:  Immunol Lett       Date:  1990-08       Impact factor: 3.685

8.  Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium.

Authors:  N Qureshi; K Takayama; E Ribi
Journal:  J Biol Chem       Date:  1982-10-10       Impact factor: 5.157

9.  A rationale for the prophylactic use of monophosphoryl lipid A in sepsis and septic shock.

Authors:  G L Gustafson; M J Rhodes
Journal:  Biochem Biophys Res Commun       Date:  1992-01-15       Impact factor: 3.575

10.  Interleukin 6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis.

Authors:  M Mihara; M Ikuta; Y Koishihara; Y Ohsugi
Journal:  Eur J Immunol       Date:  1991-10       Impact factor: 5.532

View more
  5 in total

1.  Alterations in frequency of interleukin-2 (IL-2)-, gamma interferon-, or IL-4-secreting splenocytes induced by Candida albicans mannan and/or monophosphoryl lipid A.

Authors:  S P Li; S I Lee; J E Domer
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

2.  Lack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis.

Authors:  R E Garner; J E Domer
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

3.  Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity.

Authors:  P L Fidel; M E Lynch; D H Conaway; L Tait; J D Sobel
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

Review 4.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

5.  Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model.

Authors:  Dhammika H M L P Navarathna; Kenneth W Nickerson; Gerald E Duhamel; Thomas R Jerrels; Thomas M Petro
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.